| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PAO Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0008 |
| 52 Week High | US$0.0033 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | -42.86% |
| 3 Month Change | 14.29% |
| 1 Year Change | 100.00% |
| 3 Year Change | -88.73% |
| 5 Year Change | -66.67% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PAOG | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -20.0% | -1.5% | -3.2% |
| 1Y | 100.0% | 9.7% | 19.3% |
Return vs Industry: PAOG exceeded the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: PAOG exceeded the US Market which returned 19.3% over the past year.
Price Volatility
| PAOG volatility | |
|---|---|
| PAOG Average Weekly Movement | 33.7% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PAOG's share price has been volatile over the past 3 months.
Volatility Over Time: PAOG's weekly volatility has decreased from 3415% to 34% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jim DiPrima | www.pao.group |
PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.
PAO Group, Inc. Fundamentals Summary
| PAOG fundamental statistics | |
|---|---|
| Market cap | US$1.53m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs PAOG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PAOG income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PAOG perform over the long term?
See historical performance and comparison